Home › Products › Oncology › Pazonue 200mg Tablet
Pazonue 200mg Tablet
Salt Composition: PAZOPANIB
- Manufacturer: LUCIEN LIFE SCIENCES
- Pack Size: 30 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 200MG
- Prescription Required
- Storage: Store Pazonue 200mg Tablet in room temperature (25°C) Keep the injection away from the reach of children and pets. If you forgot to take a dose, take it as soon as you remember. However, skip the missed dose if it is nearly time for the next dose. Do not take a double dose to make up for a forgotten dose.
₹3281.00₹4687.50
Inclusive of all taxes
Product Introduction
Pazonue 200mg Tablet contains pazopanib, an antineoplastic agent and tyrosine kinase inhibitor. It is indicated in adults for treatment of advanced renal cell carcinoma with metastatic disease and for certain soft-tissue sarcomas affecting connective tissues. The medicine functions by inhibiting protein activity involved in tumour cell growth and dissemination.
Do not use Pazonue 200mg Tablet if you have hypersensitivity to pazopanib or any tablet component. Inform your doctor before starting treatment if you have renal impairment, cardiac disease, pulmonary disease, hepatic dysfunction, coagulation disorders, gastrointestinal pathology, or thyroid disease. This tablet may elevate blood pressure; regular monitoring during treatment is necessary.
Patients with renal disease do not require dose adjustment. Your doctor will recommend discontinuing Pazonue 200mg Tablet at least 7 days prior to surgical procedures or dental interventions, as it may compromise wound healing. Use is not recommended in patients under 18 years of age. Consult your doctor regarding potential infertility effects before initiating therapy.
The most frequently reported adverse effects are diarrhoea, hypertension, hair colour changes, nausea, and vomiting.
Uses
Pazonue 200mg uses are: Advanced renal cell carcinoma Advanced soft tissue sarcoma
How it works
Pazonue 200mg Tablet is a biological agent that acts as targeted drug therapy in cancer treatment. It is an anticancer medication that belongs to the tyrosine kinase inhibitor class. It interferes with the growth of blood vessels inside the cancer cells by acting against a protein called Vascular Endothelial Growth Factor (VEGF) to shrink cancer cells, ultimately stopping their growth and multiplication.
How to Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Do not take this medicine with food, as it affects the absorption of this medicine. Take Pazonue 200mg Tablet at least two hours after a meal or one hour before a meal.
Side Effects
Pazonue side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Hypertension Hair Colour change Increased glucose levels Decreased weight, decrease in appetite Diarrhea Nausea, vomiting Muscle and joint pain Headache Shortness of breath Tiredness Serious Heart problems Bleeding from the anus, mouth Hypothyroidism Interstitial lung disease Infections
References
- Highlights Of Prescribing Information - Pazopanib. [Revised on 2021] [cited 2023 Mar 24]. Available from: https://www.novartis.com/us-en/sites/novartis_us/files/votrient.pdf
- Summary Of Product Characteristics - Pazopanib. [revised on 2021] [cited 2023 Mar 24]. Available from: https://www.ema.europa.eu/en/documents/product-information/votrient-epar-product-information_en.pdf
- Votrient 400 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk . 2021 [cited 2023 Mar 24]. Available from: https://www.medicines.org.uk/emc/product/572/smpc
- Edward Chu, Cancer Chemotherapy, Langeâs Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
Safety Advice
Pregnancy: Unsafe Pazonue 200mg Tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for at least 2 weeks after your last dose is necessary.
Lungs: Consult Your Doctor It is unknown whether Pazonue 200mg Tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: Unsafe Breastfeeding is not recommended in patients taking Biopanib 400mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.